Analyzing the surge in digital device usage post-pandemic, its link to anxiety and sleep issues, and evidence-based strategies for digital detox and generational wellness. Post-pandemic screen time sp...
Plant-based diets are surging globally, with studies showing up to 25% lower heart disease risk and 30% reduced emissions, driven by health and sustainability trends. The rise of plant-based diets is ...
This article analyzes the rise of digital well-being trends, including mindfulness apps and workplace initiatives, in response to increasing tech-related mental health issues, backed by recent data an...
Advancements in AI and genetic testing enable tailored nutrition plans, shifting from generic guidelines to precision health for better chronic disease management and wellness. AI and genetics merge t...
Research shows muscularis macrophages in the gut trigger α-synuclein misfolding in Parkinson’s disease, spreading to the brain via immune pathways, with potential for early intervention through...
Life Biosciences receives FDA clearance for the first human trial of cellular reprogramming targeting glaucoma and NAION, signaling regulatory openness to longevity therapies and potential vision rest...
Analytical exploration of how geroscience, epigenetic reprogramming, and AI-driven therapies are converging to extend healthspan, with insights on clinical trials, societal impacts, and future trends....
A Nature Aging study shows mitochondrial stress enhances senolytic drugs like navitoclax, improving senescent cell removal by 40% with metabolic interventions. New research reveals mitochondrial stres...
Recent neuroscience studies reveal that functional amyloids, regulated by chaperone proteins, are essential for long-term memory, challenging traditional views and offering new therapeutic avenues for...
The FDA has greenlit the first human trial of ER-100, a partial epigenetic reprogramming therapy targeting age-related eye diseases, marking a pivotal step in anti-aging and regenerative medicine. A l...
